Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
McCartney M. How the UK regulator became the herbalists' marketeer. BMJ 2014;348:g3194. [Ref.ID 98013]
2.Enlace a cita original Cita con resumen
Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013;75:603-18. [Ref.ID 95037]
3.
Skalli S, Bencheikh RS. Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Saf 2012;35:785-91. [Ref.ID 93810]
4.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
5. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
6. Cita con resumen
Lapi F, Gallo E, Giocaliere E, Vietri M, Baronti R, Pieraccini G, Tafi A, Menniti-Ippolito F, Mugelli A, Firenzuoli F, Vannacci A. Acute liver damage due to Serenoa rapens: a case report. Br J Clin Pharmacol 2010;69:558-60. [Ref.ID 88446]
7.Enlace a cita original
Bosch M, Bonafont X. Efecte de l'ús de plantes medicinals en el període perioperatori. Butlletí d'Informació Terapèutica 2009;21:19-24. [Ref.ID 86922]
8.
Agbabiaka TB, Pittler MH, Wider B, Ernst E. Serenoa repens (saw palmetto): a systematic review of adverse events. Drug Saf 2009;32:637-47. [Ref.ID 86588]
9.Tiene citas relacionadas
Bent S, Kane C, Avins AL. Saw palmetto for benign prostatic hyperplasia. The authors reply. N Engl J Med 2006;354:1950-1. [Ref.ID 76920]
10.Tiene citas relacionadas
Dimitrakov JD. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:1950. [Ref.ID 76919]
11.Tiene citas relacionadas
Casner PR. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:1950. [Ref.ID 76918]
12.Tiene citas relacionadas
DiPaola RS, Morton RA. Proven and unproven therapy for benign prostatic hyperplasia. N Engl J Med 2006;354:632-4. [Ref.ID 76142]
13.Tiene citas relacionadas Cita con resumen
Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:557-66. [Ref.ID 76137]
14.
Ernst E. Are herbal medicines effective?. Int J Clin Pharmacol Ther 2004;42:157-9. [Ref.ID 69376]
15. Cita con resumen
Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003;361:1359-67. [Ref.ID 65789]
16. Cita con resumen
Anónimo. Managing lower urinary tract symptoms in men. Drug Ther Bull 2003;41:18-21. [Ref.ID 65442]
17. Cita con resumen
Anónimo. Dutasteride (Avodart) for benign prostatic hyperplasia. Med Lett Drugs Ther 2002;44:109-10. [Ref.ID 64552]
18. Cita con resumen
Pandha HS, Kirby RS. PC-SPES: phytotherapy for prostate cancer. Lancet 2002;359:2213-4. [Ref.ID 62928]
19. Cita con resumen
Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61:2163-75. [Ref.ID 60400]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>